Piperazine compounds as drugs of abuse

被引:95
作者
Arbo, M. D. [1 ]
Bastos, M. L. [1 ]
Carmo, H. F. [1 ]
机构
[1] Univ Porto, REQUIMTE, Toxicol Lab, Dept Biol Sci,Fac Pharm, P-4099030 Oporto, Portugal
关键词
Piperazine designer drugs; Metabolism; Mechanism of action; Analysis; N-SUBSTITUTED PIPERAZINES; DESIGNER DRUGS; IN-VIVO; TOXICOLOGICAL DETECTION; LIQUID-CHROMATOGRAPHY; BENZYLPIPERAZINE BZP; PARTY PILLS; 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE TFMPP; 1-(3-CHLOROPHENYL)PIPERAZINE MCPP; META-CHLOROPHENYLPIPERAZINE;
D O I
10.1016/j.drugalcdep.2011.10.007
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Synthetic drugs are among the most commonly abused drugs in the world. This abuse is widespread among young people, especially in the dance club and rave scenes. Over the last several years, piperazine derived drugs have appeared, mainly available via the internet, and sold as ecstasy pills or under the names of "Frenzy", "Bliss", "Charge", "Herbal ecstasy", "A2", "Legal X" and "Legal E". Although in the market piperazine designer drugs have the reputation of being safe, several experimental and epidemiological studies indicate risks for humans. Piperazine designer drugs can be divided into two classes, the benzylpiperazines such as N-benzylpiperazine (BZP) and its methylenedioxy analogue 1-(3,4-methylenedioxybenzyl)piperazine (MDBP), and the phenylpiperazines such as 1-(3-chlorophenyl)piperazine (mCPP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP), and 1-(4-methoxyphenyl)piperazine (MeOPP). Toxicokinetic properties, including metabolic pathways, actions and effects in animals and humans, with some hypothesis of mechanism of action, and analytical approaches for the identification of these drugs are summarized in this review. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:174 / 185
页数:12
相关论文
共 63 条
[1]   Treatment of adolescent rats with 1-benzylpiperazine: a preliminary study of subsequent behavioral effects [J].
Aitchison, Lara K. ;
Hughes, Robert N. .
NEUROTOXICOLOGY AND TERATOLOGY, 2006, 28 (04) :453-458
[2]  
Alansari Mohammed, 2006, N Z Med J, V119, pU1959
[3]   Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants [J].
Antia, U. ;
Lee, H. S. ;
Kydd, R. R. ;
Tingle, M. D. ;
Russell, B. R. .
FORENSIC SCIENCE INTERNATIONAL, 2009, 186 (1-3) :63-67
[4]   Validation of an LC-MS Method for the Detection and Quantification of BZP and TFMPP and their Hydroxylated Metabolites in Human Plasma and its Application to the Pharmacokinetic Study of TFMPP in Humans [J].
Antia, Ushtana ;
Tingle, Malcolm D. ;
Russell, Bruce R. .
JOURNAL OF FORENSIC SCIENCES, 2010, 55 (05) :1311-1318
[5]  
Antia U, 2009, NEW ZEAL MED J, V122, P29
[6]   Metabolic interactions with piperazine-based 'party pill' drugs [J].
Antia, Ushtana ;
Tingle, Malcolm D. ;
Russell, Bruce R. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (07) :877-882
[7]  
Austin Helen, 2004, Australas Psychiatry, V12, P406, DOI 10.1111/j.1440-1665.2004.02137.x
[8]   Fatal brain oedema after ingestion of ecstasy and benzylpiperazine [J].
Balmelli, C ;
Kupferschmidt, H ;
Rentsch, K ;
Schneemann, M .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (28-29) :809-811
[9]   Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry [J].
Barroso, M. ;
Costa, S. ;
Dias, M. ;
Vieira, D. N. ;
Queiroz, J. A. ;
Lopez-Rivadulla, M. .
JOURNAL OF CHROMATOGRAPHY A, 2010, 1217 (40) :6274-6280
[10]   N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') [J].
Baumann, MH ;
Clark, RD ;
Budzynski, AG ;
Partilla, JS ;
Blough, BE ;
Rothman, RB .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (03) :550-560